Literature DB >> 7846687

Frequent overexpression of vascular endothelial growth factor gene in human renal cell carcinoma.

K Sato1, K Terada, T Sugiyama, S Takahashi, M Saito, M Moriyama, H Kakinuma, Y Suzuki, M Kato, T Kato.   

Abstract

Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen and an inducer of angiogenesis. Expression of the VEGF gene was investigated in 20 patients with renal cell carcinoma by Northern blot hybridization analysis. Of the 20 tumors, 12 (60%) overexpressed the gene 3.0 times more than in normal renal tissues. No significant correlation was found between overexpression of the VEGF gene and the histopathological data such as grade, cellular and structural subtypes, stage and size of tumor. These results suggest that VEGF is produced by the tumor cells and is responsible for development of this hypervascular tumor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7846687     DOI: 10.1620/tjem.173.355

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  14 in total

1.  Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells.

Authors:  M Gorospe; J M Egan; B Zbar; M Lerman; L Geil; I Kuzmin; N J Holbrook
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

2.  Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2.

Authors:  K M Lonergan; O Iliopoulos; M Ohh; T Kamura; R C Conaway; J W Conaway; W G Kaelin
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

Review 3.  Mechanisms of tumor invasion and metastasis.

Authors:  J A Lawrence; P S Steeg
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

4.  Influence of the RNA-binding protein HuR in pVHL-regulated p53 expression in renal carcinoma cells.

Authors:  Stefanie Galbán; Jennifer L Martindale; Krystyna Mazan-Mamczarz; Isabel López de Silanes; Jinshui Fan; Wengong Wang; Jochen Decker; Myriam Gorospe
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

5.  Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.

Authors:  O Iliopoulos; A P Levy; C Jiang; W G Kaelin; M A Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

6.  Determination of vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas and the role of overexpression in leiomyosarcoma.

Authors:  Anil Potti; Apar Kishor Ganti; Ketki Tendulkar; Kaley Sholes; Sidharth Chitajallu; Michael Koch; Steven Kargas
Journal:  J Cancer Res Clin Oncol       Date:  2003-11-05       Impact factor: 4.553

7.  Catalyser-21(TM), a mineral water derived from leaf soil, inhibits tumor cell invasion and angiogenesis.

Authors:  Jun Ye; Yuping Li; Takeki Hamasaki; Noboru Nakamichi; Takeshi Kawahara; Kazuhiro Osada; Kiichiro Teruya; Yuko Kato; Kazuko Toh; Masumi Abe; Yoshinori Katakura; Katsumi Noguchi; Sanetaka Shirahata
Journal:  Cytotechnology       Date:  2007-07-20       Impact factor: 2.058

Review 8.  VHL, the story of a tumour suppressor gene.

Authors:  Lucy Gossage; Tim Eisen; Eamonn R Maher
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

9.  Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.

Authors:  R E Banks; M A Forbes; S E Kinsey; A Stanley; E Ingham; C Walters; P J Selby
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

10.  Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E.

Authors:  P A Scott; K Smith; R Poulsom; A De Benedetti; R Bicknell; A L Harris
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.